ertumaxomab - CISMeF

Preferred Label : ertumaxomab;

MeSH note : trifunctional anti-HER2 x anti-CD3 antibody for treatment of metastatic breast cancer; in Phase I trial (5/2006);

Is substance : O;

UNII : L5L45YGP1O;

Details

Origin ID

C511895;

UMLS CUI

C1723386;

Currated CISMeF NLP mapping
- Ertumaxomab [NCIt concept]
MeSH indexing information
- antibodies, bispecific [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Record concept(s)
- ertumaxomab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ertumaxomab [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients